Insight into the mechanisms of action of estrogen receptor β in the breast, prostate, colon, and CNS

Journal of Molecular Endocrinology

Volumn 51, Issue 3, 2013, Pages

  Dey, Prasenjit ^a   Barros, Rodrigo P A ^a   Warner, Margaret ^a   Ström, Anders ^a   Gustafsson, Jan Åke ^a,b  

^a UNIVERSITY OF HOUSTON   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

3 Adiol; Anti proliferative; Cell cycle; Estrogen receptors

Indexed keywords

AROMATASE INHIBITOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FINASTERIDE; FULVESTRANT; PLACEBO; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

ANDROGEN METABOLISM; ANOREXIA; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BRANCHING MORPHOGENESIS; BREAST CANCER; BREAST METASTASIS; CANCER CELL CULTURE; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CENTRAL NERVOUS SYSTEM TUMOR; COLON CANCER; COLORECTAL CANCER; DRUG SENSITIVITY; EPITHELIAL MESENCHYMAL TRANSITION; ESTROGEN ACTIVITY; FEEDING BEHAVIOR; G1 PHASE CELL CYCLE CHECKPOINT; GLUCOSE HOMEOSTASIS; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; HYPOTHALAMUS; LIGAND BINDING; LONG TERM CARE; MIGRATION INHIBITION; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; PSYCHOPHYSIOLOGY; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TREATMENT RESPONSE;

3Β-ADIOL; ANTI-PROLIFERATIVE; CELL CYCLE; ESTROGEN RECEPTORS;

BREAST NEOPLASMS; CELL CYCLE; CENTRAL NERVOUS SYSTEM; COLONIC NEOPLASMS; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 84888329808     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-13-0150     Document Type: Article

References (169)

1. Antal MC, Krust A, Chambon P & Mark M 2008 Sterility and absence of histopathological defects in nonreproductive organs of a mouse ERb-null mutant. PNAS 105 2433-2438. (doi:10.1073/pnas. 0712029105).
2. Armstrong CM, Billimek AR, Allred KF, Sturino JM, Weeks BR & Allred CD 2013 A novel shift in estrogen receptor expression occurs as estradiol suppresses inflammation-associated colon tumor formation. Endocrine-Related Cancer 20 515-525. (doi:10.1530/ERC-12-0308).
3. AttiaDM& Ederveen AG 2012 Opposing roles of ERa and ERb in the genesis and progression of adenocarcinoma in the rat ventral prostate. Prostate 72 1013-1022. (doi:10.1002/pros.21507).
4. Barros RP & Gustafsson JA 2011 Estrogen receptors and the metabolic network. Cell Metabolism 14 289-299. (doi:10.1016/j.cmet.2011.08.005).
5. Barros RP, Gabbi C, Morani A, Warner M & Gustafsson JA 2009 Participation of ERa and ERb in glucose homeostasis in skeletal muscle and white adipose tissue. American Journal of Physiology. Endocrinology and Metabolism 297 E124-E133. (doi:10.1152/ajpendo.00189.2009).
6. Benjamins JA 2013 Direct effects of secretory products of immune cells on neurons and glia. Journal of Neurological Sciences 333 30-36. (doi:10. 1016/j.jns.2013.06.001).
7. Bielecki A, Roberts J, Mehta R & Raju J 2011 Estrogen receptor-b mediates the inhibition of DLD-1 human colon adenocarcinoma cells by soy isoflavones. Nutrition and Cancer 63 139-150. (doi:10.1080/01635581. 2010.516867).
8. Boon WC, Chow JD & Simpson ER 2010 The multiple roles of estrogens and the enzyme aromatase. Progress in Brain Research 181 209-232. (doi:10.1016/S0079-6123(08)81012-6).
9. Bosland MC 2000 The role of steroid hormones in prostate carcinogenesis. Journal of the National Cancer Institute. Monographs 2000 (27) 39-66. (doi:10.1093/oxfordjournals.jncimonographs.a024244).
10. Brenner RM, West NB & McClellan MC 1990 Estrogen and progestin receptors in the reproductive tract of male and female primates. Biology of Reproduction 42 11-19. (doi:10.1095/biolreprod42.1.11).
11. Briganti A 2009 Oestrogens and prostate cancer: novel concepts about an old issue. European Urology 55 543-545. (doi:10.1016/j.eururo.2008. 12.004).
12. Butt AJ, McNeil CM, Musgrove EA & Sutherland RL 2005 Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclinD1and cyclin E. Endocrine-Related Cancer 12 (Suppl 1) S47-S59. (doi:10.1677/erc.1.00993).
13. Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger TR et al. 2005 Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122 33-43. (doi:10.1016/j.cell.2005.05.008).
14. Carson-Jurica MA, Schrader WT & O'Malley BW 1990 Steroid receptor family: structure and functions. Endocrine Reviews 11 201-220. (doi:10.1210/edrv-11-2-201).
15. Chen Y, Chen L, Li JY, Mukaida N, Wang Q, Yang C, Yin WJ, Zeng XH, Jin W & Shao ZM 2011 ERb and PEA3 co-activate IL-8 expression and promote the invasion of breast cancer cells. Cancer Biology & Therapy 11 497-511. (doi:10.4161/cbt.11.5.14667).
16. Chen P, Hover CV, Lindberg D & Li C 2012 Central urocortin 3 and type 2 corticotropin-releasing factor receptor in the regulation of energy homeostasis: critical involvement of the ventromedial hypothalamus. Frontiers in Endocrinology 3 180. (doi:10.3389/fendo.2012.00180).
17. Cheng J, Lee EJ, Madison LD & Lazennec G 2004 Expression of estrogen receptor b in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis. FEBS Letters 566 169-172. (doi:10.1016/j.febslet.2004.04.025).
18. Cheng G, Butler R, Warner M, Gustafsson JA, Wilczek B & Landgren BM 2013 Effects of short-term estradiol and norethindrone acetate treatment on the breasts of normal postmenopausal women. Menopause 20 496-503. (doi:10.1097/GME.0b013e318276c4ea).
19. Clark JA, Alves S, Gundlah C, Rocha B, Birzin ET, Cai SJ, Flick R, Hayes E, Ho K, Warrier S et al. 2012 Selective estrogen receptor-b (SERM-b) compounds modulate raphe nuclei tryptophan hydroxylase-1 (TPH-1) mRNA expression and cause antidepressant-like effects in the forced swim test. Neuropharmacology 63 1051-1063. (doi:10.1016/j.neuropharm. 2012.07.004).
20. Clarke RB, Howell A, Potten CS & Anderson E 1997 Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Research 57 4987-4991.
21. Cleveland AG, Oikarinen SI, Bynote KK, Marttinen M, Rafter JJ, Gustafsson JA, Roy SK, Pitot HC, Korach KS, Lubahn DB et al. 2009 Disruption of estrogen receptor signaling enhances intestinal neoplasia in Apc(Min/C) mice. Carcinogenesis 30 1581-1590. (doi:10.1093/carcin/bgp132).
22. Couse JF & Korach KS 1999 Estrogen receptor null mice: what have we learned and where will they lead us? Endocrine Reviews 20 358-417. (doi:10.1210/er.20.3.358).
23. Culig Z & Santer FR 2012 Androgen receptor co-activators in the regulation of cellular events in prostate cancer. World Journal of Urology 30 297-302. (doi:10.1007/s00345-011-0797-6).
24. Darbre PD & Charles AK 2010 Environmental oestrogens and breast cancer: evidence for combined involvement of dietary, household and cosmetic xenoestrogens. Anticancer Research 30 815-827.
25. Dey P, Jonsson P, Hartman J, Williams C, Strom A & Gustafsson JA 2012 Estrogen receptors b1 and b2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3. Molecular Endocrinology 26 1991-2003. (doi:10.1210/me.2012. 1227).
26. Dey P, Ström A & Gustafsson J-Å 2013 Estrogen receptor b upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer. Oncogene [in press]. (doi:10.1038/onc.2013.384).
27. Dubik D & Shiu RP 1992 Mechanism of estrogen activation of c-myc oncogene expression. Oncogene 7 1587-1594.
28. Eckel LA 2011 The ovarian hormone estradiol plays a crucial role in the control of food intake in females. Physiology & Behavior 104 517-524. (doi:10.1016/j.physbeh.2011.04.014).
29. Edvardsson K, Strom A, Jonsson P, Gustafsson JA & Williams C 2011 Estrogen receptor b induces antiinflammatory and antitumorigenic networks in colon cancer cells. Molecular Endocrinology 25 969-979. (doi:10.1210/me.2010-0452).
30. Edvardsson K, Nguyen-Vu T, Kalasekar SM, Ponten F, Gustafsson JA & Williams C 2013 Estrogen receptor b expression induces changes in the microRNA pool in human colon cancer cells. Carcinogenesis 34 1431-1441. (doi:10.1093/carcin/bgt067).
31. Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskjold M & Gustafsson JA 1997 Human estrogen receptor b-gene structure, chromosomal localization, and expression pattern. Journal of Clinical Endocrinology and Metabolism 82 4258-4265. (doi:10.1210/jc.82.12.4258).
32. Esslimani-Sahla M, Simony-Lafontaine J, Kramar A, Lavaill R, Mollevi C, Warner M, Gustafsson JA & Rochefort H 2004 Estrogen receptor b (ERb) level but not its ERbcx variant helps to predict tamoxifen resistance in breast cancer. Clinical Cancer Research 10 5769-5776. (doi:10.1158/1078-0432.CCR-04-0389).
33. Ewan KB, Oketch-Rabah HA, Ravani SA, Shyamala G, Moses HL & Barcellos-Hoff MH 2005 Proliferation of estrogen receptor-a-positive mammary epithelial cells is restrained by transforming growth factor-b1 in adult mice. American Journal of Pathology 167 409-417. (doi:10.1016/S0002-9440(10)62985-9).
34. Fan X, Warner M & Gustafsson JA 2006 Estrogen receptor b expression in the embryonic brain regulates development of calretininimmunoreactive GABAergic interneurons. PNAS 103 19338-19343. (doi:10.1073/pnas.0609663103).
35. Fernandez SV & Russo J 2010 Estrogen and xenoestrogens in breast cancer. Toxicologic Pathology 38 110-122. (doi:10.1177/0192623309354108).
36. Forster C, Makela S, Warri A, Kietz S, Becker D, Hultenby K, Warner M & Gustafsson JA 2002 Involvement of estrogen receptor b in terminal differentiation of mammary gland epithelium. PNAS 99 15578-15583. (doi:10.1073/pnas.192561299).
37. Fujimura T, Takahashi S, Urano T, Ogawa S, Ouchi Y, Kitamura T, Muramatsu M & Inoue S 2001 Differential expression of estrogen receptor b (ERb) and its C-terminal truncated splice variant ERbcx as prognostic predictors in human prostatic cancer. Biochemical and Biophysical Research Communications 289 692-699. (doi:10.1006/bbrc. 2001.6038).
38. Fuster-Matanzo A, Llorens-Martin M, Hernandez F & Avila J 2013 Role of neuroinflammation in adult neurogenesis and Alzheimer disease: therapeutic approaches. Mediators of Inflammation 2013 260925. (doi:10.1155/2013/260925).
39. Gingrich JR, Barrios RJ, Morton RA, Boyce BF, DeMayo FJ, Finegold MJ, Angelopoulou R, Rosen JM & Greenberg NM 1996 Metastatic prostate cancer in a transgenic mouse. Cancer Research 56 4096-4102.
40. Gosden JR, Middleton PG & Rout D 1986 Localization of the human oestrogen receptor gene to chromosome 6q24/q27 by in situ hybridization. Cytogenetics and Cell Genetics 43 218-220. (doi:10.1159/000132325).
41. Gotoh K, Masaki T, Chiba S, Ando H, Fujiwara K, Shimasaki T, Mitsutomi K, Katsuragi I, Kakuma T, Sakata T et al. 2013 Brain-derived neurotrophic factor, corticotropin-releasing factor, and hypothalamic neuronal histamine interact to regulate feeding behavior. Journal of Neurochemistry 125 588-598. (doi:10.1111/jnc.12213).
42. Gruber CJ, TschugguelW, Schneeberger C & Huber JC 2002 Production and actions of estrogens. New England Journal of Medicine 346 340-352. (doi:10.1056/NEJMra000471).
43. Grubisha MJ, Cifuentes ME, Hammes SR & Defranco DB 2012 A local paracrine and endocrine network involving TGFb, Cox-2, ROS, and estrogen receptor b influences reactive stromal cell regulation of prostate cancer cell motility. Molecular Endocrinology 26 940-954. (doi:10.1210/me.2011-1371).
44. Guerini V, Sau D, Scaccianoce E, Rusmini P, Ciana P, Maggi A, Martini PG, Katzenellenbogen BS, Martini L, Motta M et al. 2005 The androgen derivative 5a-androstane-3b,17b-diol inhibits prostate cancer cell migration through activation of the estrogen receptor b subtype. Cancer Research 65 5445-5453. (doi:10.1158/0008-5472.CAN-04-1941).
45. Guiraud JM, Morfin R, Ducouret B, Samperez S & Jouan P 1979 Pituitary metabolism of 5a-androstane-3b-17b-diol: intense and rapid conversion into 5a-androstane-3b,6a,17b-triol and 5a-androstane-3b,7a, 17b-triol. Steroids 34 241-248. (doi:10.1016/0039-128X (79)90076-X).
46. Gutierrez MC, Detre S, Johnston S, Mohsin SK, Shou J, Allred DC, Schiff R, Osborne CK & Dowsett M 2005 Molecular changes in tamoxifenresistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase. Journal of Clinical Oncology 23 2469-2476. (doi:10.1200/JCO.2005.01.172).
47. Haeger P, Andres ME, Forray MI, Daza C, Araneda S & Gysling K 2006 Estrogen receptors a and b differentially regulate the transcriptional activity of the Urocortin gene. Journal of Neuroscience 26 4908-4916. (doi:10.1523/JNEUROSCI.0476-06.2006).
48. Hankinson SE, Colditz GA & Willett WC 2004 Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Research 6 213-218. (doi:10.1186/bcr921).
49. Harden JL & Egilmez NK 2012 Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity. Immunological Investigations 41 738-764. (doi:10.3109/08820139.2012.676122).
50. Hartman J, Edvardsson K, Lindberg K, Zhao C, Williams C, Strom A & Gustafsson JA 2009 Tumor repressive functions of estrogen receptor b in SW480 colon cancer cells. Cancer Research 69 6100-6106. (doi:10.1158/0008-5472.CAN-09-0506).
51. He YQ, Sheng JQ, Ling XL, Fu L, Jin P, Yen L& Rao J 2012 Estradiol regulates miR-135b and mismatch repair gene expressions via estrogen receptorb in colorectal cells. Experimental & Molecular Medicine 44 723-732. (doi:10.3858/emm.2012.44.12.079).
52. Hopp TA, Weiss HL, Parra IS, Cui Y, Osborne CK & Fuqua SA 2004 Low levels of estrogen receptor b protein predict resistance to tamoxifen therapy in breast cancer. Clinical Cancer Research 10 7490-7499. (doi:10.1158/1078-0432.CCR-04-1114).
53. Horvath TL 2006 Synaptic plasticity in energy balance regulation. Obesity 14 (Suppl 5) 228S-233S. (doi:10.1038/oby.2006.314).
54. HurtadoA, Pinos T, Barbosa-DesonglesA, Lopez-Aviles S, Barquinero J, Petriz J, Santamaria-Martinez A, Morote J, de Torres I, Bellmunt J et al. 2008 Estrogen receptor b displays cell cycle-dependent expressionand regulates the G1 phase through a non-genomicmechanism in prostate carcinoma cells. Cellular Oncology 30 349-365. (doi:10.3233/CLO-2009-0495).
55. Imamov O, Lopatkin NA & Gustafsson JA 2004 Estrogen receptor b in prostate cancer. New England Journal of Medicine 351 2773-2774. (doi:10.1056/NEJM200412233512622).
56. Isaacs JT, McDermott IR & Coffey DS 1980 The identification and characterization of the C19O3 steroid metabolites of 5a-androstane-3b,17b-diol produced by the canine prostate: 5a-androstane-3b,6a,17b-triol and 5a-androstane-3b,7a,17b-triol. Steroids 35 139-156. (doi:10.1016/0039-128X(80)90099-9).
57. Jassam N, Bell SM, Speirs V & Quirke P 2005 Loss of expression of oestrogen receptor b in colon cancer and its association with Dukes' staging. Oncology Reports 14 17-21.
58. Javid SH, Moran AE, Carothers AM, Redston M & Bertagnolli MM 2005 Modulation of tumor formation and intestinal cell migration by estrogens in the Apc(Min/C) mouse model of colorectal cancer. Carcinogenesis 26 587-595. (doi:10.1093/carcin/bgh346).
59. Kim TJ, Lee A, Choi YJ, Song BJ, Yim HW & Kang CS 2012 Prognostic significance of high expression of ER-b in surgically treated ER-positive breast cancer following endocrine therapy. Journal of Breast Cancer 15 79-86. (doi:10.4048/jbc.2012.15.1.79).
60. Konstantinopoulos PA, Kominea A, Vandoros G, Sykiotis GP, Andricopoulos P, Varakis I, Sotiropoulou-BonikouG&Papavassiliou AG 2003 Oestrogen receptor b (ERb) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. European Journal of Cancer 39 1251-1258. (doi:10.1016/S0959-8049(03)00239-9).
61. Koutsilieri E, LutzMB & Scheller C 2013 Autoimmunity, dendritic cells and relevance for Parkinson's disease. Journal of Neural Transmission 120 75-81. (doi:10.1007/s00702-012-0842-7).
62. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S & Gustafsson JA 1996 Cloning of a novel receptor expressed in rat prostate and ovary. PNAS 93 5925-5930. (doi:10.1073/pnas.93.12.5925).
63. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S & Gustafsson JA 1997 Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors a and b. Endocrinology 138 863-870. (doi:10.1210/en.138.3.863).
64. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B & Gustafsson JA 1998 Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor b. Endocrinology 139 4252-4263. (doi:10.1210/en.139.10.4252).
65. Kumar S, Patel R, Moore S, Crawford DK, Suwanna N, Mangiardi M & Tiwari-Woodruff SK 2013 Estrogen receptor b ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis. Neurobiological Disorders 56 131-144. (doi:10.1016/j.nbd.2013.04.005).
66. Lai JS, Brown LG, True LD, Hawley SJ, Etzioni RB, Higano CS, Ho SM, Vessella RL & Corey E 2004 Metastases of prostate cancer express estrogen receptor-b. Urology 64 814-820. (doi:10.1016/j.urology.2004. 05.036).
67. Lattrich C, Schuler S, Haring J, Skrzypczak M, Ortmann O & Treeck O 2013 Effects of a combined treatment with tamoxifen and estrogen receptor b agonists on human breast cancer cell lines. Archives of Gynecology and Obstetrics [in press]. (doi:10.1007/s00404-013-2977-7).
68. Lazennec G, Bresson D, Lucas A, Chauveau C & Vignon F 2001 ERb inhibits proliferation and invasion of breast cancer cells. Endocrinology 142 4120-4130. (doi:10.1210/en.142.9.4120).
69. Lechner D, Kallay E & Cross HS 2005 Phytoestrogens and colorectal cancer prevention. Vitamins and Hormones 70 169-198.
70. Lee MT, Ouyang B, Ho SM & Leung YK 2013 Differential expression of estrogen receptor b isoforms in prostate cancer through interplay between transcriptional and translational regulation. Molecular and Cellular Endocrinology 376 125-135. (doi:10.1016/j.mce.2013.06.023).
71. Le Romancer M, Poulard C, Cohen P, Sentis S, Renoir JM & Corbo L 2011 Cracking the estrogen receptor's posttranslational code in breast tumors. Endocrine Reviews 32 597-622. (doi:10.1210/er.2010-0016).
72. Leung YK, Gao Y, Lau KM, Zhang X & Ho SM 2006a ICI 182,780-regulated gene expression in DU145 prostate cancer cells is mediated by estrogen receptor-b/NFkB crosstalk. Neoplasia 8 242-249. (doi:10.1593/neo. 05853).
73. Leung YK, Mak P, Hassan S & Ho SM 2006b Estrogen receptor (ER)-b isoforms: a key to understanding ER-b signaling. PNAS 103 13162-13167. (doi:10.1073/pnas.0605676103).
74. Leung YK, Lam HM, Wu S, Song D, Levin L, Cheng L, Wu CL & Ho SM 2010 Estrogen receptor b2 and b5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion. Endocrine-Related Cancer 17 675-689. (doi:10.1677/ERC-09-0294).
75. Li S, Han B, Liu G, Li S, Ouellet J, Labrie F & Pelletier G 2010 Immunocytochemical localization of sex steroid hormone receptors in normal human mammary gland. Journal of Histochemistry and Cytochemistry 58 509-515. (doi:10.1369/jhc.2009.954644).
76. Li W, Winters A, Poteet E, Ryou MG, Lin S, Hao S, Wu Z, Yuan F, Hatanpaa KJ, Simpkins JWet al. 2013 Involvement of estrogen receptor b5 in the progression of glioma. Brain Research 1503 97-107. (doi:10.1016/j.brainres.2013.02.004).
77. Lindberg K, Helguero LA, Omoto Y, Gustafsson JA & Haldosen LA 2011 Estrogen receptor b represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity. Breast Cancer Research 13 R43. (doi:10.1186/bcr2865).
78. Love RR & Philips J 2002 Oophorectomy for breast cancer: history revisited. Journal of the National Cancer Institute 94 1433-1434. (doi:10.1093/jnci/94.19.1433).
79. Ma Y, Lovekamp-Swan T, Bekele W, Dohi A & Schreihofer DA 2013 Hypoxia-inducible factor and vascular endothelial growth factor are targets of dietary soy during acute stroke in female rats. Endocrinology 154 1589-1597. (doi:10.1210/en.2012-2120).
80. Maggiolini M, Bonofiglio D, Marsico S, Panno ML, Cenni B, Picard D & Ando S 2001 Estrogen receptor a mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Molecular Pharmacology 60 595-602.
81. Mak P, Leav I, Pursell B, Bae D, Yang X, Taglienti CA, Gouvin LM, Sharma VM & Mercurio AM 2010 ERb impedes prostate cancer EMT by destabilizing HIF-1a and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading. Cancer Cell 17 319-332. (doi:10.1016/j.ccr.2010.02.030).
82. Mak P, Chang C, Pursell B & Mercurio AM 2013 Estrogen receptor b sustains epithelial differentiation by regulating prolyl hydroxylase 2 transcription. PNAS 110 4708-4713. (doi:10.1073/pnas.1221654110).
83. Malamas MS, Manas ES, McDevitt RE, Gunawan I, Xu ZB, Collini MD, Miller CP, Dinh T, Henderson RA, Keith JC Jr et al. 2004 Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-b ligands. Journal of Medicinal Chemistry 47 5021-5040. (doi:10.1021/jm049719y).
84. Markey GC, Cullen R, Diggin P, Hill AD, Mc Dermott EW, O'Higgins NJ & Duffy MJ 2009 Estrogen receptor-b mRNA is associated with adverse outcome in patients with breast cancer. Tumour Biology 30 171-175. (doi:10.1159/000236409).
85. McCarthyM2013 Finasteride for prostate cancer prevention has no effect on survival, study finds. BMJ 347 f5203. (doi:10.1136/bmj.f5203).
86. McGaha TL, Huang L, Lemos H, Metz R, Mautino M, Prendergast GC & Mellor AL 2012 Amino acid catabolism: a pivotal regulator of innate and adaptive immunity. Immunological Reviews 249 135-157. (doi:10.1111/j.1600-065X.2012.01149.x).
87. McGlynn LM, Tovey S, Bartlett JM, Doughty J, Cooke TG & Edwards J 2013 Interactions between MAP kinase and oestrogen receptor in human breast cancer. European Journal of Cancer 49 1176-1186. (doi:10.1016/j.ejca.2012.11.020).
88. McPherson SJ, Hussain S, Balanathan P, Hedwards SL, Niranjan B, Grant M, Chandrasiri UP, Toivanen R, Wang Y, Taylor RA et al. 2010 Estrogen receptor-b activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFa mediated. PNAS 107 3123-3128. (doi:10.1073/pnas.0905524107).
89. Miller TW, Balko JM, Fox EM, Ghazoui Z, Dunbier A, Anderson H, DowsettM, Jiang A, Smith RA, Maira SMet al. 2011 ERa-dependent E2F transcription canmediate resistance to estrogen deprivation in human breast cancer. Cancer Discovery 1 338-351. (doi:10.1158/2159-8290.CD-11-0101).
90. Moore JT, McKee DD, Slentz-Kesler K, Moore LB, Jones SA, Horne EL, Su JL, Kliewer SA, Lehmann JM & Willson TM 1998 Cloning and characterization of human estrogen receptor b isoforms. Biochemical and Biophysical Research Communications 247 75-78. (doi:10.1006/bbrc. 1998.8738).
91. Murphy LC & Watson PH 2006 Is oestrogen receptor-b a predictor of endocrine therapy responsiveness in human breast cancer? Endocrine-Related Cancer 13 327-334. (doi:10.1677/erc.1.01141).
92. Murphy LC&Leygue E 2012 The role of estrogen receptor-b in breast cancer. Seminars in Reproductive Medicine 30 5-13. (doi:10.1055/s-0031-1299592).
93. Musatov S, Chen W, Pfaff DW, Mobbs CV, Yang XJ, Clegg DJ, Kaplitt MG & Ogawa S 2007 Silencing of estrogen receptor a in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. PNAS 104 2501-2506. (doi:10.1073/pnas.0610787104).
94. Muschamp JW & Hull EM 2007 Melanin concentrating hormone and estrogen receptor-a are coexstensive but not coexpressed in cells of male rat hypothalamus. Neuroscience Letters 427 123-126. (doi:10.1016/j.neulet.2007.09.031).
95. Musgrove EA & Sutherland RL 2009 Biological determinants of endocrine resistance in breast cancer. Nature Reviews. Cancer 9 631-643. (doi:10.1038/nrc2713).
96. Naftolin F 2008 Sex steroids and the brain. Gynecological Endocrinology 24 533-534. (doi:10.1080/09513590802296104).
97. Nahon JL 2006 The melanocortins and melanin-concentrating hormone in the central regulation of feeding behavior and energy homeostasis. Comptes Rendus Biologies 329 623-638 (discussion 653-655). (doi:10.1016/j.crvi.2006.03.021).
98. Nakajima Y, Akaogi K, Suzuki T, Osakabe A, Yamaguchi C, Sunahara N, Ishida J, Kako K, Ogawa S, Fujimura T et al. 2011 Estrogen regulates tumor growth through a nonclassical pathway that includes the transcription factors ERb and KLF5. Science Signaling 4 ra22. (doi:10.1126/scisignal.2001551).
99. Nehra R, Riggins RB, Shajahan AN, Zwart A, Crawford AC & Clarke R 2010 BCL2 and CASP8 regulation by NF-kB differentially affect mitochondrial function and cell fate in antiestrogen-sensitive and-resistant breast cancer cells. FASEB Journal 24 2040-2055. (doi:10.1096/fj.09-138305).
100. Nilsson S, Koehler KF & Gustafsson JA 2011 Development of subtypeselective oestrogen receptor-based therapeutics. Nature Reviews. Drug Discovery 10 778-792. (doi:10.1038/nrd3551).
101. Njiaju UO & Olopade OI 2012 Genetic determinants of breast cancer risk: a review of current literature and issues pertaining to clinical application. Breast Journal 18 436-442. (doi:10.1111/j.1524-4741.2012.01274.x).
102. Ogawa S, Inoue S, Watanabe T, Orimo A, Hosoi T, Ouchi Y & MuramatsuM 1998 Molecular cloning and characterization of human estrogen receptor bcx: a potential inhibitor of estrogen action in human. Nucleic Acids Research 26 3505-3512. (doi:10.1093/nar/26.15.3505).
103. Omoto Y, Imamov O, Warner M & Gustafsson JA 2005 Estrogen receptor a and imprinting of the neonatal mouse ventral prostate by estrogen. PNAS 102 1484-1489. (doi:10.1073/pnas.0409168102).
104. Osterlund MK 2010 Underlying mechanisms mediating the antidepressant effects of estrogens. Biochimica et Biophysica Acta 1800 1136-1144. (doi:10.1016/j.bbagen.2009.11.001).
105. Paige LA, Christensen DJ, Gron H, Norris JD, Gottlin EB, Padilla KM, Chang CY, Ballas LM, Hamilton PT, McDonnell DP et al. 1999 Estrogen receptor (ER) modulators each induce distinct conformational changes in ERa and ERb. PNAS 96 3999-4004. (doi:10.1073/pnas.96.7.3999).
106. Paoloni-Giacobino A, Chen H, Peitsch MC, Rossier C & Antonarakis SE 1997 Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3. Genomics 44 309-320. (doi:10.1006/geno.1997.4845).
107. Paruthiyil S, Parmar H, Kerekatte V, Cunha GR, Firestone GL & Leitman DC 2004 Estrogen receptor b inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Research 64 423-428. (doi:10.1158/0008-5472.CAN-03-2446).
108. Pettersson K & Gustafsson JA 2001 Role of estrogen receptor b in estrogen action. Annual Review of Physiology 63 165-192. (doi:10.1146/annurev. physiol.63.1.165).
109. Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engstrom O, Ljunggren J, Gustafsson JA & Carlquist M 1999 Structure of the ligand-binding domain of oestrogen receptor b in the presence of a partial agonist and a full antagonist. EMBO Journal 18 4608-4618. (doi:10.1093/emboj/18.17.4608).
110. Pillot B, Duraffourd C, Begeot M, Joly A, Luquet S, Houberdon I, Naville D, Vigier M, Gautier-Stein A, Magnan C et al. 2011 Role of hypothalamic melanocortin system in adaptation of food intake to food protein increase in mice. PLoS ONE 6 e19107. (doi:10.1371/journal.pone. 0019107).
111. Pravettoni A, Mornati O, Martini PG, Marino M, Colciago A, Celotti F, Motta M & Negri-Cesi P 2007 Estrogen receptor b (ERb) and inhibition of prostate cancer cell proliferation: studies on the possible mechanism of action in DU145 cells. Molecular and Cellular Endocrinology 263 46-54. (doi:10.1016/j.mce.2006.08.008).
112. Price RH Jr, Butler CA, Webb P, Uht R, Kushner P & Handa RJ 2001 A splice variant of estrogen receptor b missing exon 3 displays altered subnuclear localization and capacity for transcriptional activation. Endocrinology 142 2039-2049. (doi:10.1210/en.142.5.2039).
113. Prins GS & Birch L 1997 Neonatal estrogen exposure up-regulates estrogen receptor expression in the developing and adult rat prostate lobes. Endocrinology 138 1801-1809. (doi:10.1210/en.138.5.1801).
114. Raval AP, Borges-Garcia R, JavierMoreno W, Perez-PinzonMA&BramlettH 2013 Periodic 17b-estradiol pretreatment protects rat brain from cerebral ischemic damage via estrogen receptor-b. PLoS ONE 8 e60716. (doi:10.1371/journal.pone.0060716).
115. Rice S, Patel B, Bano G, Ugwumadu A & Whitehead SA 2012 Aromatase expression in abdominal omental/visceral and subcutaneous fat depots: a comparison of pregnant and obese women. Fertility and Sterility 97 1460-1466 (e1461). (doi:10.1016/j.fertnstert.2012.03.008).
116. Riggio M, Polo ML, Blaustein M, Colman-Lerner A, Luthy I, Lanari C & Novaro V 2012 PI3K/AKT pathway regulates phosphorylation of steroid receptors, hormone independence and tumor differentiation in breast cancer. Carcinogenesis 33 509-518. (doi:10.1093/carcin/bgr303).
117. Roepke TA 2009 Oestrogen modulates hypothalamic control of energy homeostasis through multiple mechanisms. Journal of Neuroendocrinology 21 141-150. (doi:10.1111/j.1365-2826.2008.01814.x).
118. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC et al. 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. Journal of the American Medical Association 288 321-333. (doi:10.1001/jama.288.3.321).
119. Rudolph A, Toth C, Hoffmeister M, Roth W, Herpel E, Jansen L, Marx A, Brenner H & Chang-Claude J 2012 Expression of oestrogen receptor b and prognosis of colorectal cancer. British Journal of Cancer 107 831-839. (doi:10.1038/bjc.2012.323).
120. Saji S, Jensen EV, Nilsson S, Rylander T, Warner M & Gustafsson JA 2000 Estrogen receptors a and b in the rodent mammary gland. PNAS 97 337-342. (doi:10.1073/pnas.97.1.337).
121. Saji S, Omoto Y, Shimizu C, Warner M, Hayashi Y, Horiguchi S, Watanabe T, Hayashi S, Gustafsson JA & Toi M 2002 Expression of estrogen receptor (ER) (b)cx protein in ER(a)-positive breast cancer: specific correlation with progesterone receptor. Cancer Research 62 4849-4853.
122. Saleiro D, Murillo G, Lubahn DB, Kopelovich L, Korach KS & Mehta RG 2010 Enhanced induction of mucin-depleted foci in estrogen receptor {b} knockout mice. Cancer Prevention Research 3 1198-1204. (doi:10.1158/1940-6207.CAPR-10-0044).
123. Saleiro D, Murillo G, Benya RV, Bissonnette M, Hart J & Mehta RG 2012 Estrogen receptor-b protects against colitis-associated neoplasia in mice. International Journal of Cancer 131 2553-2561. (doi:10.1002/ijc. 27578).
124. Sanchez ER 2012 Chaperoning steroidal physiology: lessons from mouse genetic models of Hsp90 and its cochaperones. Biochimica et Biophysica Acta 1823 722-729. (doi:10.1016/j.bbamcr.2011.11.006).
125. Schulze H & Barrack ER 1987 Immunocytochemical localization of estrogen receptors in the normal male and female canine urinary tract and prostate. Endocrinology 121 1773-1783. (doi:10.1210/endo-121-5-1773).
126. Schulze H & Claus S 1990 Histological localization of estrogen receptors in normal and diseased human prostates by immunocytochemistry. Prostate 16 331-343. (doi:10.1002/pros.2990160408).
127. Setlur SR, Mertz KD, Hoshida Y, Demichelis F, Lupien M, Perner S, Sboner A, Pawitan Y, Andren O, Johnson LA et al. 2008 Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. Journal of the National Cancer Institute 100 815-825. (doi:10.1093/jnci/djn150).
128. Shaaban AM, O'Neill PA, DaviesMP, Sibson R, West CR, Smith PH & Foster CS 2003 Declining estrogen receptor-b expression defines malignant progression of human breast neoplasia. American Journal of Surgical Pathology 27 1502-1512. (doi:10.1097/00000478-200312000-00002).
129. Shao TC, Castaneda E, Rosenfield RL & Liao S 1975 Selective retention and formation of a D5-androstenediol-receptor complex in cell nuclei of the rat vagina. Journal of Biological Chemistry 250 3095-3100.
130. Shiota M, Yokomizo A, Masubuchi D, Tada Y, Inokuchi J, Eto M, Uchiumi T, Fujimoto N & Naito S 2010 Tip60 promotes prostate cancer cell proliferation by translocation of androgen receptor into the nucleus. Prostate 70 540-554. (doi:10.1002/pros.21088).
131. Siegel R, Naishadham D & Jemal A 2013 Cancer statistics, 2013. CA: A Cancer Journal for Clinicians 63 11-30. (doi:10.3322/caac.21166).
132. Slusarz A, Jackson GA, Day JK, Shenouda NS, Bogener JL, Browning JD, Fritsche KL, MacDonald RS, Besch-Williford CL & Lubahn DB 2012 Aggressive prostate cancer is prevented in ERaKO mice and stimulated in ERbKO TRAMP mice. Endocrinology 153 4160-4170. (doi:10.1210/en. 2012-1030).
133. de Souza FS, Nasif S, Lopez-Leal R, Levi DH, Low MJ & Rubinsten M 2011 The estrogen receptor a colocalizes with proopiomelanocortin in hypothalamic neurons and binds to a conserved motif present in the neuron-specific enhancer nPE2. European Journal of Pharmacology 660 181-187. (doi:10.1016/j.ejphar.2010.10.114).
134. Speirs V, Skliris GP, Burdall SE & Carder PJ 2002 Distinct expression patterns of ERa and ERb in normal human mammary gland. Journal of Clinical Pathology 55 371-374. (doi:10.1136/jcp.55.5.371).
135. Stertz L, Magalhaes PV & Kapczinski F 2013 Is bipolar disorder an inflammatory condition? The relevance ofmicroglial activation Current Opinion in Psychiatry 26 19-26. (doi:10.1097/YCO.0b013e32835aa4b4).
136. Stewart ME, Pochi PE, Strauss JS, Wotiz HH & Clark SJ 1977 In-vitro metabolism of [3H]testosterone by scalp and back skin: conversion of testosterone into 5a-androstane-3b, 17b-diol. Journal of Endocrinology 72 385-390. (doi:10.1677/joe.0.0720385).
137. Stocco C 2012 Tissue physiology and pathology of aromatase. Steroids 77 27-35. (doi:10.1016/j.steroids.2011.10.013).
138. Strom A, Hartman J, Foster JS, Kietz S, Wimalasena J & Gustafsson JA 2004 Estrogen receptor b inhibits 17b-estradiol-stimulated proliferation of the breast cancer cell line T47D. PNAS 101 1566-1571. (doi:10.1073/pnas.0308319100).
139. Sugiura H, Toyama T, Hara Y, Zhang Z, Kobayashi S, Fujii Y, Iwase H & Yamashita H 2007 Expression of estrogen receptor b wild-type and its variant ERbcx/b2 is correlated with better prognosis in breast cancer. Japanese Journal of Clinical Oncology 37 820-828. (doi:10.1093/jjco/hym114).
140. Sun PM, GaoM, Wei LH, Mustea A, Wang JL, Konsgen D, LichteneggerW& Sehouli J 2006 An estrogen receptor a-dependent regulation of estrogen receptor-related receptor a in the proliferation of endometrial carcinoma cells. International Journal of Gynecological Cancer 16 (Suppl 2) 564-568. (doi:10.1111/j.1525-1438.2006.00697.x).
141. Sun Y, Jiang X & Price BD 2010 Tip60: connecting chromatin to DNA damage signaling. Cell Cycle 9 930-936. (doi:10.4161/cc.9.5.10931).
142. Suzuki H, Barros RP, Sugiyama N, Krishnan V, Yaden BC, Kim HJ, WarnerM & Gustafsson JA 2013 Involvement of estrogen receptor b in maintenance of serotonergic neurons of the dorsal raphe. Molecular Psychiatry 18 674-680. (doi:10.1038/mp.2012.62).
143. Taplin ME & Ho SM 2001 Clinical review 134: The endocrinology of prostate cancer. Journal of Clinical Endocrinology and Metabolism 86 3467-3477. (doi:10.1210/jc.86.8.3467).
144. Taylor JA, Richter CA, Suzuki A, Watanabe H, Iguchi T, Coser KR, Shioda T & vom Saal FS 2012 Dose-related estrogen effects on gene expression in fetal mouse prostate mesenchymal cells. PLoS ONE 7 e48311. (doi:10. 1371/journal.pone.0048311).
145. Teng J, Wang ZY, Jarrard DF& Bjorling DE 2008 Roles of estrogen receptor a and b in modulating urothelial cell proliferation. Endocrine-Related Cancer 15 351-364. (doi:10.1677/erc.1.01255).
146. Theoharides TC, Asadi S & Patel AB 2013 Focal brain inflammation and autism. Journal of Neuroinflammation 10 46. (doi:10.1186/1742-2094-10-46).
147. Thomas C & Gustafsson JA 2011 The different roles of ER subtypes in cancer biology and therapy. Nature Reviews. Cancer 11 597-608. (doi:10.1038/nrc3093).
148. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R et al. 2005 Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310 644-648. (doi:10.1126/science.1117679).
149. Tsurusaki T, Aoki D, Kanetake H, Inoue S, Muramatsu M, Hishikawa Y & Koji T 2003 Zone-dependent expression of estrogen receptors a and b in human benign prostatic hyperplasia. Journal of Clinical Endocrinology and Metabolism 88 1333-1340. (doi:10.1210/jc.2002-021015).
150. Vinayagam R, Sibson DR, Holcombe C, Aachi V & Davies MP 2007 Association of oestrogen receptor b2 (ERb2/ERbcx) with outcome of adjuvant endocrine treatment for primary breast cancer-a retrospective study. BMC Cancer 7 131. (doi:10.1186/1471-2407-7-131).
151. Wada-Hiraike O, Imamov O, Hiraike H, Hultenby K, Schwend T, Omoto Y, Warner M & Gustafsson JA 2006 Role of estrogen receptor b in colonic epithelium. PNAS 103 2959-2964. (doi:10.1073/pnas.0511271103).
152. Walter P, Green S, Greene G, Krust A, Bornert JM, Jeltsch JM, Staub A, Jensen E, Scrace G, Waterfield M et al. 1985 Cloning of the human estrogen receptor cDNA. PNAS 82 7889-7893. (doi:10.1073/pnas.82. 23.7889).
153. Wang L, Andersson S, Warner M & Gustafsson JA 2003 Estrogen receptor (ER)b knockout mice reveal a role for ERb in migration of cortical neurons in the developing brain. PNAS 100 703-708. (doi:10.1073/pnas.242735799).
154. Wang C, Mayer JA, Mazumdar A, Fertuck K, Kim H, Brown M & Brown PH 2011 Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor. Molecular Endocrinology 25 1527-1538. (doi:10.1210/me.2011-1037).
155. Wang H, Li Q & Chen H 2012 Genistein affects histone modifications on Dickkopf-related protein 1 (DKK1) gene in SW480 human colon cancer cell line. PLoS ONE 7 e40955. (doi:10.1371/journal.pone.0040955).
156. Webb P, Nguyen P, Valentine C, Lopez GN, Kwok GR, McInerney E, Katzenellenbogen BS, Enmark E, Gustafsson JA, Nilsson S et al. 1999 The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Molecular Endocrinology 13 1672-1685. (doi:10.1210/me.13. 10.1672).
157. Webb P, Valentine C, Nguyen P, Price RH Jr, Marimuthu A, West BL, Baxter JD & Kushner PJ 2003 ERb binds N-CoR in the presence of estrogens via an LXXLL-like motif in the N-CoR C-terminus. Nuclear Receptor 1 4. (doi:10.1186/1478-1336-1-4).
158. Weihua Z, Lathe R, Warner M & Gustafsson JA 2002a An endocrine pathway in the prostate, ERb, AR, 5a-androstane-3b,17b-diol, and CYP7B1, regulates prostate growth. PNAS 99 13589-13594. (doi:10.1073/pnas.162477299).
159. Weihua Z, Warner M & Gustafsson JA 2002b Estrogen receptor b in the prostate. Molecular and Cellular Endocrinology 193 1-5. (doi:10.1016/S0303-7207(02)00089-8).
160. White R, Lees JA, Needham M, Ham J & Parker M 1987 Structural organization and expression of the mouse estrogen receptor. Molecular Endocrinology 1 735-744. (doi:10.1210/mend-1-10-735).
161. Wu WF, Tan XJ, Dai YB, Krishnan V, Warner M & Gustafsson JA 2013 Targeting estrogen receptor b in microglia and T cells to treat experimental autoimmune encephalomyelitis. PNAS 110 3543-3548. (doi:10.1073/pnas.1300313110).
162. Xu B, Goulding EH, Zang K, Cepoi D, Cone RD, Jones KR, Tecott LH & Reichardt LF 2003 Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nature Neuroscience 6 736-742. (doi:10.1038/nn1073).
163. Xu J, Wu RC & O'Malley BW 2009 Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family. Nature Reviews. Cancer 9 615-630. (doi:10.1038/nrc2695).
164. Xue B, Zhang Z, Beltz TG, Johnson RF, Guo F, Hay M & Johnson AK 2013 Estrogen receptor-b in the paraventricular nucleus and rostroventrolateral medulla plays an essential protective role in aldosterone/saltinduced hypertension in female rats. Hypertension 61 1255-1262. (doi:10.1161/HYPERTENSIONAHA.111.00903).
165. Yang GS, Wang Y, Wang P & Chen ZD 2007 Expression of oestrogen receptor-a and oestrogen receptor-b in prostate cancer. Chinese Medical Journal 120 1611-1615.
166. Yu M, Yu J, Mani RS, Cao Q, Brenner CJ, Cao X, Wang X, Wu L, Li J, Hu M et al. 2010 An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. Cancer Cell 17 443-454. (doi:10.1016/j.ccr.2010.03.018).
167. Zang YC, Halder JB, Hong J, Rivera VM & Zhang JZ 2002 Regulatory effects of estriol on T cell migration and cytokine profile: inhibition of transcription factor NF-kB. Journal of Neuroimmunology 124 106-114. (doi:10.1016/S0165-5728(02)00016-4).
168. Zhao C, Gao H, Liu Y, Papoutsi Z, Jaffrey S, Gustafsson JA & Dahlman-Wright K 2010 Genome-wide mapping of estrogen receptor-b-binding regions reveals extensive cross-talk with transcription factor activator protein-1. Cancer Research 70 5174-5183. (doi:10.1158/0008-5472. CAN-09-4407).
169. Zhou R, Lai Y, Yamabe N, Fukui M & Zhu BT 2011 Estriol has different effects from 17b-estradiol in modulating mouse splenocyte function under inflammatory conditions. Journal of Immunotoxicology 8 346-358. (doi:10.3109/1547691X.2011.617791).